KRAS mutations in tongue squamous cell carcinoma

Yusuke Akagi, Tomoyasu Tachibana, Yorihisa Orita, Yuka Gion, Hidenori Marunaka, Takuma Makino, Kentaro Miki, Naoki Akisada, Tadashi Yoshino, Kazunori Nishizaki, Yasuharu Sato

Research output: Contribution to journalArticle

Abstract

Background: p16 INK4a (p16) expression in tongue cancer (TC) is reportedly not associated with human papilloma virus (HPV). Mutations of KRAS in cancer cells are most frequently observed within codon 12. However, few reports have investigated the association between KRAS mutations and p16 status in TC. Objectives: This study aimed to evaluate the influence of KRAS mutations on TC. Methods: Clinical records and surgically resected specimens of 85 TC patients were analyzed. Tumor samples were analyzed for mutations of KRAS located within codons 12 and 13. p16 staining was performed and considered positive in cases with moderate to strong nuclear and cytoplasmic staining. Results: Positive p16 staining was observed in 10 cases (11.8%). A KRAS mutation was detected in one case (1.2%). The case with KRAS mutation showed negative p16 staining. Despite being at an early stage, the patient died of lung metastasis at 43 months from initial treatment. Conclusions and Significance:KRAS mutations are not associated with p16 expression in TC and may predict poor prognosis in TC patients. Further analysis of mutations in regions other than codons 12 and 13 of KRAS will be necessary to determine the relationship between KRAS mutations and prognosis of this disease.

Original languageEnglish
JournalActa Oto-Laryngologica
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Tongue
Tongue Neoplasms
Squamous Cell Carcinoma
Mutation
Codon
Staining and Labeling
Papillomaviridae
Negative Staining
Neoplasms
Neoplasm Metastasis
Lung

Keywords

  • KRAS
  • p16 INK4a
  • tongue cancer

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

KRAS mutations in tongue squamous cell carcinoma. / Akagi, Yusuke; Tachibana, Tomoyasu; Orita, Yorihisa; Gion, Yuka; Marunaka, Hidenori; Makino, Takuma; Miki, Kentaro; Akisada, Naoki; Yoshino, Tadashi; Nishizaki, Kazunori; Sato, Yasuharu.

In: Acta Oto-Laryngologica, 01.01.2019.

Research output: Contribution to journalArticle

@article{20c99c4fb0884e358a5b0fe7869a7397,
title = "KRAS mutations in tongue squamous cell carcinoma",
abstract = "Background: p16 INK4a (p16) expression in tongue cancer (TC) is reportedly not associated with human papilloma virus (HPV). Mutations of KRAS in cancer cells are most frequently observed within codon 12. However, few reports have investigated the association between KRAS mutations and p16 status in TC. Objectives: This study aimed to evaluate the influence of KRAS mutations on TC. Methods: Clinical records and surgically resected specimens of 85 TC patients were analyzed. Tumor samples were analyzed for mutations of KRAS located within codons 12 and 13. p16 staining was performed and considered positive in cases with moderate to strong nuclear and cytoplasmic staining. Results: Positive p16 staining was observed in 10 cases (11.8{\%}). A KRAS mutation was detected in one case (1.2{\%}). The case with KRAS mutation showed negative p16 staining. Despite being at an early stage, the patient died of lung metastasis at 43 months from initial treatment. Conclusions and Significance:KRAS mutations are not associated with p16 expression in TC and may predict poor prognosis in TC patients. Further analysis of mutations in regions other than codons 12 and 13 of KRAS will be necessary to determine the relationship between KRAS mutations and prognosis of this disease.",
keywords = "KRAS, p16 INK4a, tongue cancer",
author = "Yusuke Akagi and Tomoyasu Tachibana and Yorihisa Orita and Yuka Gion and Hidenori Marunaka and Takuma Makino and Kentaro Miki and Naoki Akisada and Tadashi Yoshino and Kazunori Nishizaki and Yasuharu Sato",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/00016489.2019.1610574",
language = "English",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - KRAS mutations in tongue squamous cell carcinoma

AU - Akagi, Yusuke

AU - Tachibana, Tomoyasu

AU - Orita, Yorihisa

AU - Gion, Yuka

AU - Marunaka, Hidenori

AU - Makino, Takuma

AU - Miki, Kentaro

AU - Akisada, Naoki

AU - Yoshino, Tadashi

AU - Nishizaki, Kazunori

AU - Sato, Yasuharu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: p16 INK4a (p16) expression in tongue cancer (TC) is reportedly not associated with human papilloma virus (HPV). Mutations of KRAS in cancer cells are most frequently observed within codon 12. However, few reports have investigated the association between KRAS mutations and p16 status in TC. Objectives: This study aimed to evaluate the influence of KRAS mutations on TC. Methods: Clinical records and surgically resected specimens of 85 TC patients were analyzed. Tumor samples were analyzed for mutations of KRAS located within codons 12 and 13. p16 staining was performed and considered positive in cases with moderate to strong nuclear and cytoplasmic staining. Results: Positive p16 staining was observed in 10 cases (11.8%). A KRAS mutation was detected in one case (1.2%). The case with KRAS mutation showed negative p16 staining. Despite being at an early stage, the patient died of lung metastasis at 43 months from initial treatment. Conclusions and Significance:KRAS mutations are not associated with p16 expression in TC and may predict poor prognosis in TC patients. Further analysis of mutations in regions other than codons 12 and 13 of KRAS will be necessary to determine the relationship between KRAS mutations and prognosis of this disease.

AB - Background: p16 INK4a (p16) expression in tongue cancer (TC) is reportedly not associated with human papilloma virus (HPV). Mutations of KRAS in cancer cells are most frequently observed within codon 12. However, few reports have investigated the association between KRAS mutations and p16 status in TC. Objectives: This study aimed to evaluate the influence of KRAS mutations on TC. Methods: Clinical records and surgically resected specimens of 85 TC patients were analyzed. Tumor samples were analyzed for mutations of KRAS located within codons 12 and 13. p16 staining was performed and considered positive in cases with moderate to strong nuclear and cytoplasmic staining. Results: Positive p16 staining was observed in 10 cases (11.8%). A KRAS mutation was detected in one case (1.2%). The case with KRAS mutation showed negative p16 staining. Despite being at an early stage, the patient died of lung metastasis at 43 months from initial treatment. Conclusions and Significance:KRAS mutations are not associated with p16 expression in TC and may predict poor prognosis in TC patients. Further analysis of mutations in regions other than codons 12 and 13 of KRAS will be necessary to determine the relationship between KRAS mutations and prognosis of this disease.

KW - KRAS

KW - p16 INK4a

KW - tongue cancer

UR - http://www.scopus.com/inward/record.url?scp=85065530352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065530352&partnerID=8YFLogxK

U2 - 10.1080/00016489.2019.1610574

DO - 10.1080/00016489.2019.1610574

M3 - Article

C2 - 31066593

AN - SCOPUS:85065530352

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

ER -